{"id":533673,"date":"2021-09-02T07:04:47","date_gmt":"2021-09-02T11:04:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-announces-participation-at-three-upcoming-investor-conferences\/"},"modified":"2021-09-02T07:04:47","modified_gmt":"2021-09-02T11:04:47","slug":"syndax-announces-participation-at-three-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-announces-participation-at-three-upcoming-investor-conferences\/","title":{"rendered":"Syndax Announces Participation at Three Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">WALTHAM, Mass.<\/span>, <span class=\"xn-chron\">Sept. 2, 2021<\/span> \/PRNewswire\/ &#8212; Syndax Pharmaceuticals, Inc. (&#8220;Syndax,&#8221; the &#8220;Company&#8221; or &#8220;we&#8221;) (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that members of its management team will participate in three upcoming virtual investor conferences:<\/p>\n<ul type=\"disc\">\n<li>A\u00a0fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference at 9:30 a.m. ET on <span class=\"xn-chron\">Thursday, September 9, 2021<\/span>. <\/li>\n<li>A panel at the Citi 16th Annual BioPharma Virtual Conference at 9:45 a.m. ET on <span class=\"xn-chron\">Friday, September 10, 2021<\/span>. <\/li>\n<li>A fireside chat at the Baird Global Healthcare Conference at 8:30 a.m. ET on <span class=\"xn-chron\">Tuesday, September 14, 2021<\/span>. <\/li>\n<\/ul>\n<p>A live webcast of the Morgan Stanley presentation and Citi panel can be accessed from the Investor section of the Company&#8217;s website at <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3277428-1&amp;h=3679279566&amp;u=http%3A%2F%2Fwww.syndax.com%2F&amp;a=www.syndax.com\" rel=\"nofollow noopener\">www.syndax.com<\/a>, where a replay of the events will also be available for a limited time.<\/p>\n<p>\n        <b>About Syndax Pharmaceuticals, Inc. <\/b>\n      <\/p>\n<p>Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The Company&#8217;s pipeline includes SNDX-5613, a highly selective inhibitor of the Menin\u2013MLL binding interaction, axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor, and entinostat, a class I HDAC inhibitor. For more information, please visit \u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3277428-1&amp;h=3679279566&amp;u=http%3A%2F%2Fwww.syndax.com%2F&amp;a=www.syndax.com\" rel=\"nofollow noopener\">www.syndax.com<\/a>\u00a0or follow the Company on\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3277428-1&amp;h=4166007121&amp;u=https%3A%2F%2Ftwitter.com%2Fsyndax%3Flang%3Den&amp;a=Twitter\" rel=\"nofollow noopener\">Twitter<\/a>\u00a0and\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3277428-1&amp;h=3966962948&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fsyndax-pharmaceuticals%2F&amp;a=LinkedIn\" rel=\"nofollow noopener\">LinkedIn<\/a>.\u00a0<\/p>\n<p>\n        <b>Syndax Contacts<\/b>\n      <\/p>\n<p>Investor Contact<br \/><span class=\"xn-person\">Melissa Forst<\/span><br \/>Argot Partners<br \/><a target=\"_blank\" href=\"mailto:melissa@argotpartners.com\" rel=\"nofollow noopener\">melissa@argotpartners.com<\/a><br \/>Tel 212.600.1902<\/p>\n<p>Media Contact<br \/><span class=\"xn-person\">Ted Held<\/span><br \/><a target=\"_blank\" href=\"mailto:ted.held@gcihealth.com\" rel=\"nofollow noopener\">ted.held@gcihealth.com<\/a><br \/>Tel 212.798.9842<\/p>\n<p>SNDX-G<\/p>\n<p>\u00a0<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE93500&amp;sd=2021-09-02\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow noopener\" href=\"https:\/\/www.prnewswire.com\/news-releases\/syndax-announces-participation-at-three-upcoming-investor-conferences-301368070.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/syndax-announces-participation-at-three-upcoming-investor-conferences-301368070.html<\/a><\/p>\n<p>SOURCE  Syndax Pharmaceuticals, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NE93500&amp;Transmission_Id=202109020700PR_NEWS_USPR_____NE93500&amp;DateId=20210902\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire WALTHAM, Mass., Sept. 2, 2021 \/PRNewswire\/ &#8212; Syndax Pharmaceuticals, Inc. (&#8220;Syndax,&#8221; the &#8220;Company&#8221; or &#8220;we&#8221;) (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that members of its management team will participate in three upcoming virtual investor conferences: A\u00a0fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference at 9:30 a.m. ET on Thursday, September 9, 2021. A panel at the Citi 16th Annual BioPharma Virtual Conference at 9:45 a.m. ET on Friday, September 10, 2021. A fireside chat at the Baird Global Healthcare Conference at 8:30 a.m. ET on Tuesday, September 14, 2021. A live webcast of the Morgan Stanley presentation and Citi panel can be accessed from the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-announces-participation-at-three-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Syndax Announces Participation at Three Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-533673","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Syndax Announces Participation at Three Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-announces-participation-at-three-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Syndax Announces Participation at Three Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire WALTHAM, Mass., Sept. 2, 2021 \/PRNewswire\/ &#8212; Syndax Pharmaceuticals, Inc. (&#8220;Syndax,&#8221; the &#8220;Company&#8221; or &#8220;we&#8221;) (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that members of its management team will participate in three upcoming virtual investor conferences: A\u00a0fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference at 9:30 a.m. ET on Thursday, September 9, 2021. A panel at the Citi 16th Annual BioPharma Virtual Conference at 9:45 a.m. ET on Friday, September 10, 2021. A fireside chat at the Baird Global Healthcare Conference at 8:30 a.m. ET on Tuesday, September 14, 2021. A live webcast of the Morgan Stanley presentation and Citi panel can be accessed from the &hellip; Continue reading &quot;Syndax Announces Participation at Three Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-announces-participation-at-three-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-02T11:04:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE93500&amp;sd=2021-09-02\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-announces-participation-at-three-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-announces-participation-at-three-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Syndax Announces Participation at Three Upcoming Investor Conferences\",\"datePublished\":\"2021-09-02T11:04:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-announces-participation-at-three-upcoming-investor-conferences\\\/\"},\"wordCount\":250,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-announces-participation-at-three-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NE93500&amp;sd=2021-09-02\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-announces-participation-at-three-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-announces-participation-at-three-upcoming-investor-conferences\\\/\",\"name\":\"Syndax Announces Participation at Three Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-announces-participation-at-three-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-announces-participation-at-three-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NE93500&amp;sd=2021-09-02\",\"datePublished\":\"2021-09-02T11:04:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-announces-participation-at-three-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-announces-participation-at-three-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-announces-participation-at-three-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NE93500&amp;sd=2021-09-02\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NE93500&amp;sd=2021-09-02\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-announces-participation-at-three-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Syndax Announces Participation at Three Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Syndax Announces Participation at Three Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-announces-participation-at-three-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Syndax Announces Participation at Three Upcoming Investor Conferences - Market Newsdesk","og_description":"PR Newswire WALTHAM, Mass., Sept. 2, 2021 \/PRNewswire\/ &#8212; Syndax Pharmaceuticals, Inc. (&#8220;Syndax,&#8221; the &#8220;Company&#8221; or &#8220;we&#8221;) (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that members of its management team will participate in three upcoming virtual investor conferences: A\u00a0fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference at 9:30 a.m. ET on Thursday, September 9, 2021. A panel at the Citi 16th Annual BioPharma Virtual Conference at 9:45 a.m. ET on Friday, September 10, 2021. A fireside chat at the Baird Global Healthcare Conference at 8:30 a.m. ET on Tuesday, September 14, 2021. A live webcast of the Morgan Stanley presentation and Citi panel can be accessed from the &hellip; Continue reading \"Syndax Announces Participation at Three Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-announces-participation-at-three-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-02T11:04:47+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE93500&amp;sd=2021-09-02","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-announces-participation-at-three-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-announces-participation-at-three-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Syndax Announces Participation at Three Upcoming Investor Conferences","datePublished":"2021-09-02T11:04:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-announces-participation-at-three-upcoming-investor-conferences\/"},"wordCount":250,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-announces-participation-at-three-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE93500&amp;sd=2021-09-02","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-announces-participation-at-three-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-announces-participation-at-three-upcoming-investor-conferences\/","name":"Syndax Announces Participation at Three Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-announces-participation-at-three-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-announces-participation-at-three-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE93500&amp;sd=2021-09-02","datePublished":"2021-09-02T11:04:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-announces-participation-at-three-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/syndax-announces-participation-at-three-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-announces-participation-at-three-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE93500&amp;sd=2021-09-02","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE93500&amp;sd=2021-09-02"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-announces-participation-at-three-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Syndax Announces Participation at Three Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533673","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=533673"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533673\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=533673"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=533673"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=533673"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}